Public Health Flashcards

1
Q

Incidence

A

The number of individuals who develop a condition in a given period of time

Units: % or per 1000

Incidence= No. of new cases during time t/ population at risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Prevalence

A

The number of individuals who have a condition at a particular time

Prevalence= No. of existing cases at time t/ total population size

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Absolute risk

A

The risk of developing a condition over a given time period

I.e 1 in 10 at risk of developing cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Absolute risk difference

A

P of case in exposed group- P of case in unexposed group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Relative risk

A

Ratio of risk in the exposed group to risk in unexposed group

RR= P of case in exposed group/ P of case in unexposed

Normally produces larger value than absolute risk difference

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

True positive

A

Number of people who have a disease who were screened as positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

True negative

A

Number of people who don’t have a disease who were screened as negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

False positive

A

Number of people who don’t have a disease but were screened as positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

False negative

A

Number of people who do have a disease but were screened as negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Sensitivity

A

The proportion of people with the disease who were correctly identified by the screening test

Sensitivity= True positive/ (true positive + false negative)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Specificity

A

The proportion of people without the disease correctly identified by the screening test

Specificity= true negative/ (true negative + false positive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Positive predictive value

A

The proportion of people with a positive result who have the condition

PPV= True positive/ (true positive + false positive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Negative predictive value

A

The proportion of people with a negative result who don’t have the condition

NPV= True negative/ (true negative + false negative)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Cross-sectional study

A

Prevalence within a population, a snapshot in time.
Exposure Outcome

+ Quick, cheap with few ethical problems and can be used to stimulate further research

  • Suffers from selection bias and has no time reference
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Case-control study

A

Comparison of a group of people with a disease and a control group. Can be used to investigate risk factors.
Outcome—> Exposure

+ Quick, cheap and works well for disease with long latent periods

  • selection/ information bias and can’t tell incidence
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cohort study (longitudinal study)

A

A systematic study (follow up) of a group of people. Can be prospective and/or retrospective
Exposure—> Outcome

+multiple outcomes, can catch rare diseases, can give incidence, identifies exposure/ confounders

  • expensive, time consuming and study power is lost from lack of follow up
17
Q

Randomised control trails

A

Randomised sample separated into treatment arm and control arm. Measure no. with + without disease in each.

+Gold standard, removes bias and confounders by randomisation, blinding and placebo

-Expensive, ethical issues and poor compliance reduces power

18
Q

Ecological study

A

Correlations within populations I.e link between smoking and lung cancer in different nations. Descriptive study

19
Q

Simple random sampling

A

Each member of the population has an equal chance of being selected

20
Q

Systematic sampling

A

Members of a population are selected at equal intervals

21
Q

Stratified sampling

A

Population separated into groups (strata) that should be similar. Random sampling then used within groups

22
Q

Cluster sampling

A

Population put into groups (clusters). Random sampling then used to selected whole groups

23
Q

Validity

A

Whether a study measures what it’s supposed to

24
Q

Reliability

A

Whether a study produces similar results consistently

25
Q

Standard deviation

A

Mean spread of data from the mean

26
Q

Odds ratio

A

Approximation of relative risk used in especially large samples

OR= no. With/ no. Without
Event occurs/ event doesn’t occur

27
Q

One unit of alcohol

A

8g/10ml of pure alcohol

28
Q

Primary prevention

A

Systems to prevent a disease ever occurring e.g. education, campaigns, legislations, restrictions

29
Q

Secondary prevention

A

To detect early disease and slow progression e.g. aspirin, b- blockers, screening

30
Q

Tertiary prevention

A

Once disease is established and symptomatic, tertiary prevention aims to reduce complications of severity of the disease

31
Q

High risk prevention

A

Targets highest risk individuals
Aim to reduce risk below set limit

Favours those who are more affluent and educated. They are:
More likely to engage with health services
More likely to comply with treatment
More likely to have the means to change their lifestyle

32
Q

Population approach to prevention

A

Targets all individuals
Aim to reduce the risk for each individual
Recognised that the low risk majority may contribute most cases
Concerns over treating the well

33
Q

Primary prevention in CHD

A

Lifestyle changes and management of related condition I.e hypertension, high cholesterol and diabetes

SNAP
Smoking(tax, legislation, cessation services, education)
Nutrition(recommendations, regulations, labelling, food in schools)
Alcohol (tax, alcohol pricing, regulation)
Physical activity

Medication: anti-hypertensives, statins, insulin